Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010

Canadian Journal of Microbiology

Volumn 58, Issue 8, 2012, Pages 1008-1017

  Demczuk, Walter H B ^a   Martin, Irene ^a   Griffith, Averil ^a   Lefebvre, Brigitte ^b   McGeer, Allison ^c   Shane, Amanda ^d   Zhanel, George G ^e   Tyrrell, Gregory J ^f   Gilmour, Matthew W ^a   Hoang, Linda ^g   Pocock, Ingrid ^g   Paccagnella, Ana ^g   Janz, Loretta ^g   Mithan, Sultana ^g   Rahim, Tazim ^g   Horsman, Greg ^h   Nagle, Evelyn ^h   Kitzul, Rosanne ^h   Bullard, Jared ^h   Van Caeseele, Paul ^h   Sitter, Denise ^h   Pillai, Dylan ^b   Gubbay, Jonathan ^b   Rawte, Prasad ^b   Couillard, Michel ⁱ   Haldane, David ^j   Doroshenko, Alexander ^k   Thibeault, Maryse ^k   Brisson, Eric ^k   Plourde, Francine ^k   Thibault, L ^k   Abbott, Lewis ^k   Stace, Melanie ^k   Delaney, Peter ^k   Turgeon, Linda ^k   Mahaney, Tammy ^k   Ang, Lei ^l   Sellers, R ^l   Robberts, L ^m   March, Sandra ^m   Case, Cheryl ⁿ   Robertson, Rosalyn ^o   Nash, Becky ^o   Cash, Chris ^o   Plevneshi, Agron ^o   Pong Porter, Sylvia ^o   Green, Karen ^o   Wong, Kenny ^o   more..

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^g Saskatchewan Disease Control Laboratory   (Canada)

^h PUBLIC HEALTH ONTARIO   (Canada)

ⁱ QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^j New Brunswick Regional Hospitals   (Canada)

^k Prince Edward Island   (Canada)

^l Newfoundland and Labrador Public Health Laboratory   (Canada)

^m Stanton Territorial Hospital   (Canada)

ⁿ Whitehorse General Hospital   (Canada)

^o Whitehorse General Hospital ^*

more..

Author keywords

Invasive pneumococcal disease; PCV13; Serotype; Streptococcus pneumoniae; Surveillance

Indexed keywords

PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

AGE STRUCTURE; BASELINE CONDITIONS; EPIDEMIOLOGY; HEALTH RISK; INVASIVE SPECIES; PUBLIC HEALTH; SPATIOTEMPORAL ANALYSIS; VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BACTERIUM ISOLATE; CANADA; CHILD; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INVASIVE SPECIES; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROTYPE; STRAIN IDENTIFICATION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

CANADA;

STREPTOCOCCUS PNEUMONIAE;

EID: 84864739199     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/W2012-073     Document Type: Article

References (50)

1. Austrian, R. 1976. The Quellung reaction, a neglected microbiologic technique. Mt. Sinai J. Med. 43(6): 699-709. PMID:13297.
2. Bettinger, J.A., Scheifele, D.W., Kellner, J.D., Halperin, S.A., Vaudry, W., Law, B., et al. 2010. The effect of routine vaccination on invasive pneumococcal infections in Canadian children, immunization monitoring program, active 2000-2007. Vaccine, 28(9): 2130-2136. doi:10.1016/j.vaccine.2009.12.026. PMID: 20044050.
3. Bjornson, G., Scheifele, D.W., Bettinger, J., Patrick, D.M., Gustafson, L., Daly, P., and Tyrrell, G.J. 2007. Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005. Pediatr. Infect. Dis. J. 26(6): 540-542. doi:10.1097/INF. 0b013e31803c56df. PMID:17529875.
4. Bruce, M.G., Deeks, S.L., Zulz, T., Bruden, D., Navarro, C., Lovgren, M., et al. 2008. International circumpolar surveillance system for invasive pneumococcal disease, 1999-2005. Emerg. Infect. Dis. 14(1): 25-33. doi:10.3201/eid1401.071315. PMID: 18258073.
5. Brueggemann, A.B., Peto, T.E., Crook, D.W., Butler, J.C., Kristinsson, K.G., and Spratt, B.G. 2004. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J. Infect. Dis. 190(7): 1203-1211. doi:10.1086/423820. PMID:15346329.
6. Centers for Disease Control and Prevention. 2011. PCR deduction of pneumococcal serotypes [online]. Available from http://www.cdc.gov/ncidod/biotech/strep/pcr.htm [accessed 6 November 2011].
7. Centers for Disease Control and Prevention, and Advisory Committee on Immunization Practices. 2010. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR, 59(34): 1102-1106. PMID:20814406.
8. Clinical Laboratory Standards Institute. 2008. Interpretative criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. MM18-A. Vol. 28, No. 12. pp. 21-24.
9. Dagan, R., Englehard, D., and Piccard, E. 1992. Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. JAMA, 268(23): 3328-3332. doi:10.1001/jama.268.23.3328. PMID:1364814.
10. Drancourt, M., Roux, V., Fournier, P.E., and Raoult, D. 2004. rpoB gene sequence-based identification of aerobic Gram-positive cocci of the genera Streptococcus, Enterococcus, Gemella, Abiotrophia, and Granulicatella. J. Clin. Microbiol. 42(2): 497-504. doi:10. 1128/JCM.42.2.497-504.2004. PMID:14766807.
11. Facklam, R.R., and Washington, J.A. 1991. Streptococcus and related catalase-negative gram-positive cocci. In Manual of clinical microbiology. Edited by A. Balows, W.J. Hausler, K.L. Hermann, H.D. Isenberg, and H.J. Shadomy. American Society for Microbiology, Washington, D.C., USA. pp. 238-257.
12. Fenoll, A., Aguilar, L., Vicioso, M.D., Gimenez, M.J., Robledo, O., and Granizo, J.J. 2011. Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009. BMC Infect. Dis. 11(1): 239. doi:10.1186/1471-2334-11-239. PMID: 21910891.
13. Hanage, W.P., Kaijalainen, T.H., Syrjanen, R.K., Auranen, K., Leinonen, M., Makela, P.H., and Spratt, B.G. 2005. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect. Immun. 73(1): 431-435. doi:10.1128/ IAI.73.1.431-435.2005. PMID:15618181.
14. Hanquet, G., Kissling, E., Fenoll, A., George, R.C., Lepoutre, A., Lernout, T., et al. 2010. Pediatric pneumococcal serotypes in children in 4 European countries. Emerg. Infect. Dis. 16(9): 1428-1439. doi:10.3201/eid1609.100102.PMID:20735928.
15. Hausdorff, W.P., Bryant, J., Kloek, C., Paradiso, P.R., and Siber, G.R. 2000. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin. Infect. Dis. 30(1): 122-140. doi:10.1086/313609. PMID:10619741.
16. Isaacman, D.J., McIntosh, E.D., and Reinert, R.R. 2010. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int. J. Infect. Dis. 14(3): e197-e209. doi:10.1016/j.ijid.2009.05.010. PMID: 19700359.
17. Kellner, J.D. 2011. Update on the success of the pneumococcal conjugate vaccine. Paediatr. Child Health, 16(4): 233-236. PMID: 22468128.
18. Kellner, J.D., Scheifele, D., Vanderkooi, O.G., Macdonald, J., Church, D.L., and Tyrrell, G.J. 2008. Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada. Pediatr. Infect. Dis. J. 27(6): 526-532. doi:10.1097/INF.0b013e3181658c5c. PMID:18458650.
19. Kellner, J.D., Vanderkooi, O.G., MacDonald, J., Church, D.L., Tyrrell, G.J., and Scheifele, D.W. 2009. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin. Infect. Dis. 49(2): 205-212. doi:10.1086/ 599827. PMID:19508165.
20. Lambertsen, L., and Kerrn, M.B. 2010. Test of a novel Streptococcus pneumoniae serotype 6C type specific polyclonal antiserum (factor antiserum 6d) and characterisation of serotype 6C isolates in Denmark. BMC Infect. Dis. 10(1): 282. doi:10.1186/1471-2334-10-282. PMID:20868480.
21. Laroche, J., Frescura, A.M., and Belzak, L. 2010. Results from the 2006 and 2009 childhood national immunization coverage surveys (NICS). Can. J. Infect. Dis. Med. Microbiol. 21(4): 205.
22. Lefebvre, B., and Bourgault, A.M. 2009. Programme de surveillance du pneumocoque, rapport 2009 [online]. Institut national de santé publique du Québec. Available from http://www.inspq.qc.ca/pdf/publications/1383_ProgSurvPneumocoque2010.pdf [accessed 6 March 2012].
23. Lexau, C.A., Lynfield, R., Danila, R., Pilishvili, T., Facklam, R., Farley, M.M., et al. 2005. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA, 294(16): 2043-2051. doi:10.1001/jama.294.16.2043. PMID:16249418.
24. Lovgren, M., Spika, J.S., and Talbot, J.A. 1998. Invasive Streptococcus pneumoniae infections: serotype distribution and anti-microbial resistance in Canada, 1992-1995. CMAJ, 158(3): 327-331. PMID:9484256.
25. Ludbrook, J. 2008. Analysis of 2 × 2 tables of frequencies: matching test to experimental design. Int. J. Epidemiol. 37(6): 1430-1435. doi:10.1093/ije/dyn162. PMID:18710887.
26. McBean, A.M., Park, Y.T., Caldwell, D., and Yu, X. 2005. Declining invasive pneumococcal disease in the U.S. elderly. Vaccine, 23(48-49): 5641-5645. doi:10.1016/j.vaccine.2005.05.043. PMID:16111788.
27. McIntosh, E.D.G., and Reinert, R.R. 2011. Global prevailing and emerging pediatric pneumococcal serotypes. Expert Rev. Vaccines, 10(1): 109-129. doi:10.1586/erv.10.145. PMID:21162625.
28. National Advisory Committee on Immunization. 2002. Statement on recommended use of pneumococcal conjugate vaccine. Canadian Communicable Disease Report. Vol. 28. PMID:12728645.
29. National Advisory Committee on Immunization. 2006. Canada immunization guide, Seventh Edition-2006 [online]. Available from http://www.phac-aspc.gc.ca/publicat/cig-gci/index-eng.php [accessed 30 March 2012].
30. National Advisory Committee on Immunization. 2010a. Update on pediatric invasive pneumococcal disease and recommended use of conjugate pneumococcal vaccines. Canadian Communicable Disease Report. Vol. 36. Advisroy Committee Statement 3. Available from http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/10pdf/36-acs-3.pdf.
31. National Advisory Committee on Immunization. 2010b. Update on the use of conjugate pneumococcal vaccines in childhood. Canadian Communicable Disease Report. Vol. 36. Advisory Committee Statement 12. Available from http://www.phac-aspc.c.ca/publicat/ccdr-rmtc/10vol36/acs-12/acs-12-eng.pdf.
32. Park, I.H., Park, S., Hollingshead, S.K., and Nahm, M.H. 2007. Genetic basis for the new pneumococcal serotype, 6C. Infect. Immun. 75(9): 4482-4489. doi:10.1128/IAI.00510-07. PMID: 17576753.
33. Pichichero, M.E., and Casey, J.R. 2007. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA, 298(15): 1772-1778. doi:10.1001/jama.298.15.1772. PMID:17940232.
34. Pilishvili, T., Lexau, C., Farley, M.M., Hadler, J., Harrison, L.H., Bennett, N.M., et al. 2010. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 201(1): 32-41. doi:10.1086/648593. PMID:19947881.
35. Public Health Agency of Canada. 2005a. Notifiable diseases on-line [online]. Available from http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/c_time-eng.php [accessed 30 March 2012].
36. Public Health Agency of Canada. 2005b. Notifiable diseases on-line [online]. Available from http://dsol-smed.phac-aspc.gc.ca/dsol-smed/ndis/list-eng.php [accessed 10 May 2012].
37. Public Health Agency of Canada. 2009. Case definitions for communicable diseases under national surveillance-2009 [online]. Available from http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/09vol35/35s2/index-eng.php [accessed 6 March 2012].
38. Public Health Agency of Canada. 2012. Vaccine-preventable diseases: invasive pneumococcal disease (2012) [online]. Available from http://www.phac-aspc.gc.ca/im/vpd-mev/pneumococcaleng.php [accessed 30 March 2012].
39. Reinert, R., Jacobs, M.R., and Kaplan, S.L. 2010. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine, 28(26): 4249-4259. doi:10.1016/j.vaccine.2010.04.020. PMID:20416266.
40. Rightmier, E., Stevens, V., and Brown, J. 2011. Streptococcus pneumoniae vaccination in older adults. Am. J. Geriatr. Pharmac other. 9(6): 392-404. doi:10.1016/j.amjopharm.2011.09.008. PMID:22047941.
41. Robinson, K.A., Baughman, W., Rothrock, G., Barrett, N.L., Pass, M., Lexau, C., et al. 2001. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998 opportunities for prevention in the conjugate vaccine era. JAMA, 285(13): 1729-1735. doi:10.1001/jama.285.13.1729. PMID:11277827.
42. Schuchat, A., Robinson, K., Wenger, J.D., Harrison, L.H., Farley, M., Reingold, A.L., et al. 1997. Bacterial meningitis in the United States in 1995. N. Engl. J. Med. 337(14): 970-976. doi:10.1056/ NEJM199710023371404. PMID:9395430.
43. Scott, J.A.G., Hall, A.J., Dagan, R., Dixon, J.M.S., Eykyn, S.J., Fenoll, A., et al. 1996. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin. Infect. Dis. 22(6): 973-981. doi:10.1093/clinids/22.6.973. PMID:8783696.
44. Shahidi, N., Dhaliwal, J., Tyrrell, G., Hoang, L., and Patrick, D. 2008. Trends in incidence of invasive pneumococcal disease following introduction of the universal infant immunization program in British Columbia, 2002-2005. BC Med. J. 50(1): 18-21.
45. Spellerberg, B., and Brandt, C. 2007. Streptococcus. In Manual of clinical microbiology. Edited by P.R. Murray, E.L. Baron, J.H. Jorgensen, M.L. Landry, and M.A. Pfaller. American Society of Microbiology, Washington, D.C., USA. pp. 412-429.
46. Trotter, C.L., Waight, P., Andrews, N.J., Slack, M., Efstratiou, A., George, R., and Miller, E. 2010. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006. J. Infect. 60(3): 200-208. doi:10.1016/j. jinf.2009.12.008. PMID:20035785.
47. Tyrrell, G.J., Lovgren, M., Chui, N., Minion, J., Garg, S., Kellner, J. D., and Marrie, T.J. 2009. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006. Vaccine, 27(27): 3553-3560. doi:10.1016/j. vaccine.2009.03.063. PMID:19464534.
48. Weinberger, D.M., Malley, R., and Lipsitch, M. 2011. Serotype replacement in disease after pneumococcal vaccination. Lancet, 378(9807): 1962-1973. doi:10.1016/S0140-6736(10)62225-8. PMID:21492929.
49. Winters, M., Patrick, D.M., Marra, F., Buxton, J., Chong, M., IsaacRenton, J.L., et al. 2008. Epidemiology of invasive pneumococcal disease in BC during the introduction of conjugated pneumococcal vaccine. Can. J. Public Health, 99(1): 57-61. PMID:18435393.
50. Zemlickova, H., Jakubu, V., Urbaskova, P., Motlova, J., Musilek, M., and Adamkova, V. 2010. Serotype-specific invasive disease potential of Streptococcus pneumoniae in Czech children. J. Med. Microbiol. 59(9): 1079-1083. doi:10.1099/jmm.0.018390-0. PMID:20508002.